Bausch + Lomb Corporation
NYSE:BLCO
17.5 (USD) • At close February 4, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Bausch + Lomb Corporation |
Symbool | BLCO |
Munteenheid | USD |
Prijs | 17.5 |
Beurswaarde | 6,162,870,525 |
Dividendpercentage | 0% |
52-weken bereik | 13.16 - 21.69 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Brenton L. Saunders J.D. |
Website | https://www.bausch.com |
An error occurred while fetching data.
Over Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)